Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Acute Lymphoblastic Leukemia
100%
Adjusted Hazard Ratio
25%
BCP-ALL
12%
Cancer Hazard
12%
Childhood Acute Lymphoblastic Leukemia
12%
Clinical Remission
12%
ETV6-RUNX1
25%
Hazard Ratio
25%
High Hyperdiploidy
12%
High Risk
100%
Improved Survival
12%
Low Activity
12%
Low Risk
100%
Maintenance Therapy
37%
Methyltransferase Activity
12%
Non-high Risk
12%
Pediatric Hematology
12%
Pediatric Oncology
12%
Second Cancer
100%
Standard Risk
50%
Subset Analysis
12%
Survival Rate
12%
Thiopurine Methyltransferase
25%
Thiopurine Therapy
12%
Thiopurines
12%
White Blood Cell Count
12%
Working Diagnosis
12%
Immunology and Microbiology
B Cell
100%
High Risk Population
100%
Leukocyte Count
100%
Precursor
100%
Survival Rate
100%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
B Cell
12%
Cell Count
12%
Hazard Ratio
50%
High Risk Population
12%
Leukocyte
12%
Maintenance Therapy
37%
Mercaptopurine
25%
Pediatric Hematology
12%
Pediatric Oncology
12%
Precursor
12%
Second Cancer
100%
Survival Rate
12%
Thiopurine Methyltransferase
25%